Innovet Remedies (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 02-07-2024
- Paid Up Capital ₹ 0.10 M
as on 02-07-2024
- Company Age 18 Year, 3 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2022)
- Profit 22.84%
(FY 2022)
- Ebitda 45.95%
(FY 2022)
- Net Worth -1083.29%
(FY 2022)
- Total Assets %
(FY 2022)
About Innovet Remedies (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Agarwal and Anurag Agarwal serve as directors at the Company.
- CIN/LLPIN
U24305KA2006PTC040551
- Company No.
040551
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 2006
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Innovet Remedies (India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anurag Agarwal  | Director | 19-Sep-2006 | Current |
| Amit Agarwal | Director | 19-Sep-2006 | Current |
Financial Performance and Corporate Structure Insights of Innovet Remedies (India).
Innovet Remedies (India) Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 22.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 1083.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovet Remedies (India)?
In 2020, Innovet Remedies (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Natural Remedies Private LimitedActive 26 years 8 monthsAmit Agarwal and Anurag Agarwal are mutual person
- Herbs (India) Private LimitedActive 49 years 10 months
Amit Agarwal and Anurag Agarwal are mutual person
Herb Artizan Private LimitedActive 6 years 1 monthAmit Agarwal and Anurag Agarwal are mutual person
- Indian Herbs Concentrates Private LimitedActive 32 years 7 months
Amit Agarwal and Anurag Agarwal are mutual person
- Natural Living Private LimitedActive 3 years 5 months
Amit Agarwal and Anurag Agarwal are mutual person
- Spot Electrotech Systems Private LimitedActive 35 years 4 months
Amit Agarwal and Anurag Agarwal are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Innovet Remedies (India)?
Unlock and access historical data on people associated with Innovet Remedies (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovet Remedies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovet Remedies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
